Detalhe da pesquisa
1.
Anatomical heterogeneity of residual disease in chronic lymphocytic leukemia treated with ibrutinib.
Hematol Oncol
; 40(5): 1105-1108, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35656838
2.
Ibrutinib dose intensity in high-risk chronic lymphocytic leukemia.
Hematol Oncol
; 40(5): 1100-1104, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35613703
3.
Immunogenicity and clinical efficacy of anti-SARS-CoV-2 vaccination in patients with hematological malignancies: Results of a prospective cohort study of 365 patients.
Am J Hematol
; 97(8): E321-E324, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35702859
4.
Immunogenicity of anti-SARS-CoV-2 Comirnaty vaccine in patients with lymphomas and myeloma who underwent autologous stem cell transplantation.
Bone Marrow Transplant
; 57(1): 137-139, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34635796